| Keryx Biopharmaceuticals, Inc. | (NQ: KERX) |
|
USD
|
|
Official Closing Price
/ Updated: /
|
| View: | Quote | News | Research |
(KERX) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 26, 2013
(Investment Underground » Page n...,
4/16/12)
In the continuously up-and-down moving stock market, most investors may tend to shy away from the word "aggressive" in any sense - especially as it relates to investing their funds. Yet,...(read more)
(Wall Street Sector Selector,
5/6/11)
Dmitry Balyasny is the founder of Balyasny Asset Management. He started his trading career at Schonfeld Securities in 1994. Balyasny’s Atlas Global fund returned 20+% average annual returns since its inception in 2002. The multistrategy hedge fund f...
(Penny Stock DD,
11/30/10)
Keryx Biopharmaceuticals, Inc. (KERX: News ) Tuesday stated that its late-stage short-term efficacy study component of the Phase 3 registration program for...(read more)
Keryx Biopharmaceuticals (KERX) Company Overview
There is no analysis for KERX yet. But you can go to Wikinvest to help create one!
